Yes ND the reality is if BD1 can deliver a worlds first blood test for Ovarian, Breast and Lung cancer then this stock will provide a lot for patient shareholders going forward.
I have a question for the forum. Does anyone know if the tests will require FDA approval in the US?
The reason I ask is 2021 is only 18 short months away.
In yhat time we will need to have successful Luminex adaptation, clinical trials, production/royalty contract/distribution contract and maybe FDA approval???....its a pretty full dance card.
Chart, page-3277
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
-0.005(1.06%) |
Mkt cap ! $52.41M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.0¢ | 46.5¢ | $9.386K | 20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 47998 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 3500 | 1 |
View Market Depth
| Last trade - 11.23am 08/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |